At JDRF, we’re leading the fight against type 1 diabetes (T1D) by funding research, advocating for policies that accelerate access to new therapies, and providing a support network for millions of people around the world impacted by T1D. JDRF is the world’s largest nonprofit funder of T1D research. Our in-house scientists oversee a diverse portfolio of research tracks, leaving no stone unturned in our search for a cure. While our focus is on curing T1D, we also pursue new treatments to keep people with T1D healthy until that day comes. Outside of the lab, we push for increased government funding for research, and work with academia, clinicians, insurers and regulators to get new therapies and devices to market quickly and safely. Our research investments deliver on the promise of making life with T1D better. We’ve championed technology with that goal in mind, from the first engineered insulin 40 years ago to recent advancements like artificial pancreas systems and more. JDRF has changed the way we live with T1D. Everyday, we are learning more about the disease in an effort to end it once and for all.